SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Emergent BioSolutions Q3 2026 Earnings Call Begins

Emergent BioSolutions' quarterly earnings call has begun.

EBS
SquawkNews Desk

Emergent BioSolutions's quarterly earnings call has just begun.Live earnings calls are not yet supported in the mobile app. To listen and follow along in real time, open TradingView website in your browser.

Related stories

Stock exchange approves NICE listing withdrawal effective Nov. 6, 2026 The stock exchange approved the withdrawal of NICE’s listing, effective November 6, 2026. M impact | EQUITY | Nov 02, 2026, 11:05 PM UTC I-80 Gold Posts Q3 Adjusted Loss of $0.06 Per Share M impact | EQUITY | Nov 02, 2026, 11:04 PM UTC I-80 Gold reports Q3 production of 11,685 ounces M impact | EQUITY | Nov 02, 2026, 11:04 PM UTC Backblaze Raises Full-Year Revenue Outlook; Shares Surge 33% After Hours Backblaze raised its full-year revenue outlook. Shares rose 33% to $9.84 in after-hours trading Monday, after closing down 2.5% at $7.40; the stock is up 59% year to date. M impact | EQUITY | Nov 02, 2026, 11:04 PM UTC AH Realty Trust Q3 Earnings Snapshot AH Realty Trust reported on Monday; the available text provides no earnings figures. M impact | EQUITY | Nov 02, 2026, 11:03 PM UTC Hinge Health Reports Q3 Revenue of $235 Million, Raises 2026 Guidance Hinge Health reported adjusted EPS of $0.71 versus FactSet consensus of $0.58. It raised its 2026 revenue outlook to $879 million-$881 million from a prior FactSet estimate of $860 M impact | EQUITY | Nov 02, 2026, 11:03 PM UTC